Adipokines are Associated With Hypertension in Metabolically Healthy Obese (MHO) Children and Adolescents: A Prospective Population-Based Cohort Study

Background The potential mechanism underlying the relationship between the risk of cardiovascular diseases and metabolically healthy obese (MHO) individuals remains unclear. The aim of the study was to prospectively investigate the potential role of the adipokines in the association between the MHO phenotype and hypertension in children and adolescents. Methods A total of 1184 participants at baseline were recruited from a cohort of the Beijing Child and Adolescent Metabolic Syndrome (BCAMS) study. The participants were classified according to their body mass index (BMI) and metabolic syndrome (MS) components. The levels of the adipokines, including leptin, adiponectin, and resistin, were measured. Results MHO individuals had higher leptin levels (11.58 ug/L vs 1.20 ug/L), leptin/adiponectin ratio (1.18 vs 0.07), and lower adiponectin (11.65 ug/L vs 15.64 ug/L) levels compared to metabolically healthy normal-weight individuals (all P < 0.05). Compared to metabolically healthy normal-weight individuals, the prevalence of high leptin levels (26.5% vs 0.4%), low adiponectin levels (17.9% vs 6.3%) and a high leptin/adiponectin ratio (26.0% vs 2.1%) was higher in MHO individuals (all P < 0.01). The MHO individuals with abnormal adipokines were significantly more likely to developing hypertension (high leptin, relative risk 11.04; 95% confidence interval, 1.18–103.35; and high leptin/adiponectin ratio, relative risk 9.88; 95% confidence interval, 1.11–87.97) compared to metabolically healthy normal-weight individuals with normal adipokine levels. Conclusions The abnormal adipokine levels contribute to the increased hypertension risk in MHO children and adolescents. The non-traditional risk factors should be highlighted in MHO children and adolescents in clinical practice and research.

[1]  J. Mi,et al.  Hypertension outcomes in metabolically unhealthy normal-weight and metabolically healthy obese children and adolescents , 2015, Journal of Human Hypertension.

[2]  S. Czernichow,et al.  Metabolically Healthy Obesity and Risk of Mortality: Does the Definition of Metabolic Health Matter? Diabetes Care 2013; 36: 2294-2300 RESPONSE , 2014 .

[3]  B. Zinman,et al.  Are Metabolically Healthy Overweight and Obesity Benign Conditions? , 2013, Annals of Internal Medicine.

[4]  F. Hu,et al.  Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. , 2013, The lancet. Diabetes & endocrinology.

[5]  I. Perry,et al.  Does inflammation determine metabolic health status in obese and nonobese adults? , 2013, The Journal of clinical endocrinology and metabolism.

[6]  J. Mi,et al.  Prevalence of metabolic syndrome in a cohort of Chinese schoolchildren: comparison of two definitions and assessment of adipokines as components by factor analysis , 2013, BMC Public Health.

[7]  G. Cho,et al.  Obesity phenotype and incident hypertension: a prospective community-based cohort study , 2013, Journal of hypertension.

[8]  J. Mi,et al.  Trends in general and abdominal obesity among Chinese children and adolescents 1993–2009 , 2012, Pediatric obesity.

[9]  S. Srinivasan,et al.  Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart Study. , 2012, American journal of epidemiology.

[10]  Chien-Jen Chen,et al.  Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. , 2012, Asia Pacific journal of clinical nutrition.

[11]  E. Stamatakis,et al.  Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. , 2012, The Journal of clinical endocrinology and metabolism.

[12]  F. Contaldo,et al.  High Leptin/Adiponectin Ratio and Serum Triglycerides Are Associated With an “At‐Risk” Phenotype in Young Severely Obese Patients , 2011, Obesity.

[13]  L. Ferrucci,et al.  Body Fat Distribution and Inflammation Among Obese Older Adults With and Without Metabolic Syndrome , 2010, Obesity.

[14]  K. Cianflone,et al.  Adiponectin and Leptin Metabolic Biomarkers in Chinese Children and Adolescents , 2010, Journal of obesity.

[15]  R. Wildman.  Healthy obesity , 2009, Current opinion in clinical nutrition and metabolic care.

[16]  M. Reilly,et al.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. , 2008, Journal of the American College of Cardiology.

[17]  Fritz Schick,et al.  Identification and characterization of metabolically benign obesity in humans. , 2008, Archives of internal medicine.

[18]  Peter Bennett,et al.  The metabolic syndrome in children and adolescents – an IDF consensus report , 2007, Pediatric diabetes.

[19]  J. Mi,et al.  [Metabolic syndrome in overweight and obese schoolchildren in Beijing]. , 2007, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[20]  T. Lam,et al.  Hypoadiponectinemia as a Predictor for the Development of Hypertension: A 5-Year Prospective Study , 2007, Hypertension.

[21]  Ho-Young Son,et al.  Epidemic obesity and type 2 diabetes in Asia , 2006, The Lancet.

[22]  K. Sargsyan,et al.  Hypoadiponectinemia as a risk factor for atherosclerosis? , 2006, Stroke.

[23]  A. Körner,et al.  Obesity in childhood and adolescence: a review in the interface between adipocyte physiology and clinical challenges. , 2005, Hormones.

[24]  P. Scherer,et al.  Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome , 2005, Journal of internal medicine.

[25]  A. Shirahata,et al.  Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. , 2003, Obesity research.

[26]  S. Heshka,et al.  Sex and race differences in fat distribution among Asian, African-American, and Caucasian prepubertal children. , 2002, The Journal of clinical endocrinology and metabolism.

[27]  D. Allison,et al.  Larger amounts of visceral adipose tissue in Asian Americans. , 2001, Obesity research.

[28]  T. Cole,et al.  Establishing a standard definition for child overweight and obesity worldwide: international survey , 2000, BMJ : British Medical Journal.

[29]  Jing Zhang,et al.  Nontraditional risk factors for cardiovascular disease and visceral adiposity index among different body size phenotypes. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[30]  Anoop Misra,et al.  Obesity and the metabolic syndrome in developing countries: focus on South Asians. , 2014, Nestle Nutrition Institute workshop series.

[31]  W. Doehner,et al.  Metabolically Healthy Obesity and Risk of Mortality:DoestheDefinitionofMetabolic Health Matter? Diabetes Care , 2014 .

[32]  Zhou Pi-ming,et al.  Development of blood pressure reference standards for Chinese children and adolescents , 2010 .

[33]  Wen-Harn Pan,et al.  Epidemiology of metabolic syndrome in Asia. , 2008, Asia Pacific journal of clinical nutrition.

[34]  M. Szalecki,et al.  [Adiponectin as an adipose tissue hormone and its role in the metabolic syndrome and cardiovascular disease]. , 2005, Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych.